MedTrace Logo

Neonatal Seizure Registry - Developmental Functional EValuation

NCT04337697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2026-02-05

No results posted yet for this study

Summary

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

Conditions

  • Neonatal Seizure
  • Hypoxic-Ischemic Encephalopathy
  • Stroke
  • Intracranial Hemorrhages
  • Epilepsy
  • Cerebral Palsy
  • Intellectual Disability

Sponsors & Collaborators

Principal Investigators

  • Hannah C. Glass, MDCM, MAS · University of California, San Francisco

Eligibility

Min Age
2 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-15
Primary Completion
2025-02-28
Completion
2025-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04337697 on ClinicalTrials.gov